Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
IEX is heading into its October 28 earnings report with a split personality: options market positioning at its most bullish extreme of the past year, while short interest has climbed 30% over the past month.
The options picture is the most striking data point this week. Calls have overwhelmed puts to a degree not seen in the past 12 months, with the put/call ratio hitting 0.076, the lowest reading in the 52-week range and nearly 1.5 standard deviations below its 20-day average of 0.165. That is a decisive shift toward call-heavy positioning, far more bullish than the ratio has been throughout most of the year, when it ran consistently above 0.24. The borrow market tells a very different story. Short interest has risen 12% over the past week and 30% over the past month, reaching 3.2% of the free float. That is not a crowded short by any measure, but the directional move is persistent. Cost to borrow has climbed 71% over the past month to 0.43%, though at that level it remains cheap and imposes no meaningful friction on new positions. Availability is extremely loose, running above any practical cap, so there is no squeeze dynamic in this lending market. The divergence between call-heavy options flow and a quietly growing short base is the clearest tension in the setup.
The Street leans positive into the print. RBC Capital raised its target to $285 this week, maintaining its Outperform rating, and the direction of analyst travel since the July results has been uniformly higher. Mizuho upgraded to Outperform in August with a target of $280, and a cluster of firms including Citigroup, TD Cowen, Stifel and Oppenheimer all lifted targets in the days following Q2 results. The consensus mean target of $256 sits about 8% above the current price of $237.19, a moderate implied upside. The bull case centres on the HST segment, where data centre, semiconductor and life sciences exposure is driving what bulls describe as multi-year durable growth. Orders rose 28% in Q2 with a book-to-bill of 1.16x, and management raised full-year EPS guidance to $8.70 to $8.85. Bears point to the roughly 50% of quarterly revenue that is booked within the quarter, limiting visibility, and flag tariff exposure, a stronger dollar, and inventory resets in life sciences and agriculture as potential headwinds. The PE multiple has expanded about 1.4 points over the past 30 days to roughly 25x, reflecting the post-August re-rating.
One ownership note worth flagging is Wellington Management, which filed an amended 13G in May showing its stake had fallen to 2.3% from 8.3%. That is a meaningful reduction from a traditionally long-only institutional holder, even if the filing reflects a position as last disclosed and Wellington may have moved further since. BlackRock and the Vanguard entities remain the largest holders at roughly 7 to 8% each, and there is no activist on the register. Insider activity has been low-signal: all recent transactions are tax-withholding events (code F) or option-exercise-and-sell sequences, not open-market purchases or discretionary sales. The net 90-day insider position is a minor negative $91,000, largely reflecting the exercise-and-sell by the general counsel in August at around $238.
The July earnings print saw the stock gain 4% on the day and extend that to 5.5% over the following five days, the only clean post-earnings reaction in the recent history available. The question heading into October 28 is whether the HST growth thesis remains intact against a macro backdrop that has been less friendly to short-cycle industrials. Among peers this week, DOV was roughly flat, SWK gained about 0.8%, while GTES, TEX and ESAB each fell 6 to 8%, and CAT dropped 10.5%. IEX's flat-to-slightly-positive week against that peer backdrop suggests relative strength, but the divergence between the call-heavy options market and a rebuilding short base means the earnings setup is worth watching closely for which side of that bet proves right.
See the live data behind this article on ORTEX.
Open IEX on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
